TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
Brief Summary: The project goal is to conduct a randomized controlled trial (RCT) to test whether mobile phone short message system (SMS) reminders, either with or without mobile-phone based travel subsidies will improve timeliness, coverage, and drop-out rates of routine EPI vaccines in rural western Kenya.


Options:
A: Arm Label: Controls; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Reminders alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminders alone | Arm Label: Reminders + compliance-linked incentives; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Reminders alone, Behavioral: Compliance-linked incentives | Intervention Type: BEHAVIORAL; Name: Reminders alone; Assigned to Arm(s): Reminders + compliance-linked incentives, Reminders alone | Intervention Type: BEHAVIORAL; Name: Compliance-linked incentives; Assigned to Arm(s): Reminders + compliance-linked incentives
B: Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Other: SMS reminder | Arm Label: SMS reminder and Travel subsidy; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder and Travel subsidy 2; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy 2 | Intervention Type: OTHER; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder and Travel subsidy, SMS reminder and Travel subsidy 2 | Intervention Type: OTHER; Name: Travel subsidy; Assigned to Arm(s): SMS reminder and Travel subsidy | Intervention Type: OTHER; Name: Travel subsidy 2; Assigned to Arm(s): SMS reminder and Travel subsidy 2
C: Arm Label: Short Message Service (SMS) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS message | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: SMS message; Assigned to Arm(s): Short Message Service (SMS) group | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: health education; Type: EXPERIMENTAL; Interventions: Other: health education | Arm Label: no health education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): health education

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
Brief Summary: The project goal is to conduct a randomized controlled trial (RCT) to test whether mobile phone short message system (SMS) reminders, either with or without mobile-phone based travel subsidies will improve timeliness, coverage, and drop-out rates of routine EPI vaccines in rural western Kenya.


Options:
A: Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Other: SMS reminder | Arm Label: SMS reminder and Travel subsidy; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder and Travel subsidy 2; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy 2 | Intervention Type: OTHER; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder and Travel subsidy, SMS reminder and Travel subsidy 2 | Intervention Type: OTHER; Name: Travel subsidy; Assigned to Arm(s): SMS reminder and Travel subsidy | Intervention Type: OTHER; Name: Travel subsidy 2; Assigned to Arm(s): SMS reminder and Travel subsidy 2
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder | Arm Label: SMS reminder + Unconditional Incentive; Type: EXPERIMENTAL; Interventions: Behavioral: SMS reminder, Behavioral: Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder + Unconditional Incentive | Intervention Type: BEHAVIORAL; Name: Unconditional Incentive; Assigned to Arm(s): SMS reminder + Unconditional Incentive
C: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: promotional Exclusive breastfeeding text messages | Arm Label: control; Type: OTHER; Interventions: Other: promotional Exclusive breastfeeding text messages | Intervention Type: OTHER; Name: promotional Exclusive breastfeeding text messages; Assigned to Arm(s): control, intervention
D: Arm Label: SmartMoms-Clinic; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: SmartMoms-Phone; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: Physician Directed; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SmartMoms; Assigned to Arm(s): SmartMoms-Clinic, SmartMoms-Phone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya
Brief Summary: The project goal is to conduct a randomized controlled trial (RCT) to test whether mobile phone short message system (SMS) reminders, either with or without mobile-phone based travel subsidies will improve timeliness, coverage, and drop-out rates of routine EPI vaccines in rural western Kenya.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Voice Reminder (Group A); Type: EXPERIMENTAL; Interventions: Behavioral: Voice Reminder (Group A) | Arm Label: Cash Incentive (Group B); Type: EXPERIMENTAL; Interventions: Behavioral: Cash Incentive (Group B) | Intervention Type: BEHAVIORAL; Name: Voice Reminder (Group A); Assigned to Arm(s): Voice Reminder (Group A) | Intervention Type: BEHAVIORAL; Name: Cash Incentive (Group B); Assigned to Arm(s): Cash Incentive (Group B)
B: Arm Label: Text-based VMMC follow-up; Type: EXPERIMENTAL; Interventions: Other: Text-based follow-up | Arm Label: Routine VMMC follow-up care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Text-based follow-up; Assigned to Arm(s): Text-based VMMC follow-up
C: Arm Label: Reminder module (SMS and Phone call); Type: EXPERIMENTAL; Interventions: Behavioral: Reminder module (SMS and Phone call) | Arm Label: Photovoice; Type: EXPERIMENTAL; Interventions: Behavioral: Photovoice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reminder module (SMS and Phone call); Assigned to Arm(s): Reminder module (SMS and Phone call) | Intervention Type: BEHAVIORAL; Name: Photovoice; Assigned to Arm(s): Photovoice
D: Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Other: SMS reminder | Arm Label: SMS reminder and Travel subsidy; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder and Travel subsidy 2; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy 2 | Intervention Type: OTHER; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder and Travel subsidy, SMS reminder and Travel subsidy 2 | Intervention Type: OTHER; Name: Travel subsidy; Assigned to Arm(s): SMS reminder and Travel subsidy | Intervention Type: OTHER; Name: Travel subsidy 2; Assigned to Arm(s): SMS reminder and Travel subsidy 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I Randomised Trial to Evaluate the Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in Bacille Calmette-Guérin (BCG) Vaccinated Adults
Brief Summary: This is a Phase I trial to evaluate the safety and immunogenicity of MVA85A-IMX313 vaccination compared to MVA85A vaccination, in BCG vaccinated adults.


Options:
A: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Biological: BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group D; Type: EXPERIMENTAL; Interventions: Biological: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu | Intervention Type: BIOLOGICAL; Name: BCG: 100 microlitres ~ 2-8 x 105 pfu; Assigned to Arm(s): Group A, Group C | Intervention Type: BIOLOGICAL; Name: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu; Assigned to Arm(s): Group B, Group D
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: FP85A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: FP85A, Biological: MVA85A | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Biological: FP85A, Biological: MVA85A | Intervention Type: BIOLOGICAL; Name: FP85A; Assigned to Arm(s): 1, 2, 3 | Intervention Type: BIOLOGICAL; Name: MVA85A; Assigned to Arm(s): 2, 3
C: Arm Label: MVA85A; Type: EXPERIMENTAL; Interventions: Biological: MVA85A, Biological: BCG Vaccine SSI | Arm Label: Candin; Type: ACTIVE_COMPARATOR; Interventions: Biological: Candin, Biological: BCG Vaccine SSI | Intervention Type: BIOLOGICAL; Name: MVA85A; Assigned to Arm(s): MVA85A | Intervention Type: BIOLOGICAL; Name: Candin; Assigned to Arm(s): Candin | Intervention Type: BIOLOGICAL; Name: BCG Vaccine SSI; Assigned to Arm(s): Candin, MVA85A
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: MVA85A-IMX313 | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA85A-IMX313 | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA85A | Intervention Type: BIOLOGICAL; Name: MVA85A-IMX313; Assigned to Arm(s): Group A, Group B | Intervention Type: BIOLOGICAL; Name: MVA85A; Assigned to Arm(s): Group C

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Cytokine Removal in Cardiopulmonary Bypass Patients Using the Cytosorb ™ Filter
Brief Summary: Cardiopulmonary bypass (CPB) surgery initiates a systemic inflammatory response induced by extrinsic (e.g. anesthesia, contact activation within the extracorporeal circuit, endotoxemia) and intrinsic (e.g. tissue damage, endothelial cell activation, ischemia-reperfusion injury of myocardium) factors. Monocytes are important players in systemic inflammation and the main producers of pro- and antiinflammatory cytokines. Monocytes activated by the extracorporeal circuit lead to a dysregulation of inflammatory homeostasis, increased levels of proinflammatory plasma mediators such as TNF-a, IL-1β, IL-6 and IL-18 are joined by antiinflammatory cytokines such as IL-10. This strong inflammatory response induces post surgical monocyte immunosuppression which is indicated by an impaired production of ex vivo LPS induced TNF-a production. Also malfunction of the peripheral circulation with increased lactate levels, pronounced fluid accumulation, increased need of vasopressors and cerebral dysfunction are observed. All of these factors may delay weaning from the ventilator, recovery of organ functions and discharge from ICU. Thus measures to decrease the inflammatory process have the potential to improve the perioperative course.

Use of cytokine adsorbing circuit during CBP has an effect on circulation cytokine levels for the first 36 hours after surgery and induces a decreased inflammatory response for up to 3 days post surgery.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Treatment | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Corticosteroid; Type: EXPERIMENTAL; Interventions: Drug: Corticosteroid | Intervention Type: DRUG; Name: Corticosteroid; Assigned to Arm(s): Corticosteroid
C: Arm Label: CytoSorb; Type: EXPERIMENTAL; Interventions: Device: CytoSorb | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: CytoSorb; Assigned to Arm(s): CytoSorb
D: Arm Label: Dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
Brief Summary: The purpose of this pilot study is to determine whether text message (and phone) communication can be effectively utilized to adjust long-acting insulin, compared to standard practice.


Options:
A: Arm Label: Medtable; Type: EXPERIMENTAL; Interventions: Behavioral: Medtable | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Medtable | Intervention Type: BEHAVIORAL; Name: Medtable; Assigned to Arm(s): Medtable, Usual care
B: Arm Label: Online disease management; Type: EXPERIMENTAL; Interventions: Behavioral: Online disease management | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Online disease management; Assigned to Arm(s): Online disease management
C: Arm Label: Mobile Insulin Titration Intervention; Type: EXPERIMENTAL; Interventions: Other: Mobile Insulin Titration Intervention | Arm Label: Current Best Practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mobile Insulin Titration Intervention; Assigned to Arm(s): Mobile Insulin Titration Intervention
D: Arm Label: Structured Education Group; Type: EXPERIMENTAL; Interventions: Behavioral: Structured Education, Drug: Scilin®M30 | Arm Label: Conventional Care Group:; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional Diabetes Education, Drug: Scilin®M30 | Intervention Type: BEHAVIORAL; Name: Structured Education; Assigned to Arm(s): Structured Education Group | Intervention Type: BEHAVIORAL; Name: Conventional Diabetes Education; Assigned to Arm(s): Conventional Care Group: | Intervention Type: DRUG; Name: Scilin®M30; Assigned to Arm(s): Conventional Care Group:, Structured Education Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Motivational Interviewing to Increase Contraception Use Among Young Women: a Randomized Control Trial
Brief Summary: Study design: This is a 2-phase study. During the first phase, the investigators developed a contraceptive counseling intervention based on the principles of Motivational Interviewing, trained counselors, and conducted a small pilot study to develop skills and refine the intervention.

The second phase is this feasibility randomized controlled trial (RCT) to compare outcomes between:

Group 1 - Women randomized to a 20-40 minute contraceptive counseling session based on the principles of motivational interviewing, vs.

Group 2 - Women receiving usual clinic care.

Population: Women, aged 15-29 years, presenting to the University of Chicago family planning clinic for termination of an unintended pregnancy.

Hypothesis: A larger proportion of women who are randomized to receive the MI counseling intervention will be using very effective contraception 3 months after the intervention.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Structured contraceptive counseling | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Structured contraceptive counseling; Assigned to Arm(s): 1
B: Arm Label: EARLY; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing plus feedback | Arm Label: Video Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Video | Arm Label: Informational Brochure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Informational Brochure | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing plus feedback; Assigned to Arm(s): EARLY | Intervention Type: BEHAVIORAL; Name: Video; Assigned to Arm(s): Video Information | Intervention Type: BEHAVIORAL; Name: Informational Brochure; Assigned to Arm(s): Informational Brochure
C: Arm Label: Group 1: Counseling Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Counseling Intervention | Arm Label: Group 2: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Counseling Intervention; Assigned to Arm(s): Group 1: Counseling Intervention
D: Arm Label: 1 Standard Care (SC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2 Standard Care + Educational (SCE); Type: OTHER; Interventions: Behavioral: educational instruction in clinic | Arm Label: 3 Standard Care + Educational + Phone Calls (SCEP); Type: OTHER; Interventions: Behavioral: educational instruction and phone follow-up | Intervention Type: BEHAVIORAL; Name: educational instruction and phone follow-up; Assigned to Arm(s): 3 Standard Care + Educational + Phone Calls (SCEP) | Intervention Type: BEHAVIORAL; Name: educational instruction in clinic; Assigned to Arm(s): 2 Standard Care + Educational (SCE)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region
Brief Summary: The goal is to build social/cultural, political/economic, and physical/built environments that will promote active play and intake of healthy food to prevent young child obesity in the Pacific Region. Our methods will support local culture in order to achieve this goal in these remote, underserved native populations. CHL will engage the community, and focus on capacity building and sustainable environmental change.

The focus of the CHL community-based program is to promote healthy eating and to increase physical activity. In order to demonstrate effectiveness, the investigators will recruit and measure children in six communities selected in each of our jurisdictions in the Pacific. These represent intervention communities, comparison communities, and temporal communities.


Options:
A: Arm Label: Healthy Children, Strong Families (first); Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Children, Strong Families, Behavioral: Child Safety | Arm Label: Child Safety (first); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy Children, Strong Families, Behavioral: Child Safety | Intervention Type: BEHAVIORAL; Name: Healthy Children, Strong Families; Assigned to Arm(s): Child Safety (first), Healthy Children, Strong Families (first) | Intervention Type: BEHAVIORAL; Name: Child Safety; Assigned to Arm(s): Child Safety (first), Healthy Children, Strong Families (first)
B: Arm Label: Treatment Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Treatment Group
C: Intervention Type: BEHAVIORAL; Name: Family Spirit curriculum; Assigned to Arm(s): N/A
D: Arm Label: CHL program; Type: EXPERIMENTAL; Interventions: Other: CHL program | Arm Label: Delayed Optimized CHL program; Type: OTHER; Interventions: Other: Delayed Optimized CHL program | Arm Label: Temporal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CHL program; Assigned to Arm(s): CHL program | Intervention Type: OTHER; Name: Delayed Optimized CHL program; Assigned to Arm(s): Delayed Optimized CHL program

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Children's Healthy Living Program for Remote Underserved Minority Populations in the Pacific Region
Brief Summary: The goal is to build social/cultural, political/economic, and physical/built environments that will promote active play and intake of healthy food to prevent young child obesity in the Pacific Region. Our methods will support local culture in order to achieve this goal in these remote, underserved native populations. CHL will engage the community, and focus on capacity building and sustainable environmental change.

The focus of the CHL community-based program is to promote healthy eating and to increase physical activity. In order to demonstrate effectiveness, the investigators will recruit and measure children in six communities selected in each of our jurisdictions in the Pacific. These represent intervention communities, comparison communities, and temporal communities.


Options:
A: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle counseling | Intervention Type: BEHAVIORAL; Name: Lifestyle counseling; Assigned to Arm(s): Lifestyle counseling
B: Arm Label: Low intensity arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary, physical activity and sleeping | Arm Label: High intensity arm; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary, physical activity and sleeping | Intervention Type: BEHAVIORAL; Name: Dietary, physical activity and sleeping; Assigned to Arm(s): High intensity arm, Low intensity arm
C: Arm Label: CHL program; Type: EXPERIMENTAL; Interventions: Other: CHL program | Arm Label: Delayed Optimized CHL program; Type: OTHER; Interventions: Other: Delayed Optimized CHL program | Arm Label: Temporal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CHL program; Assigned to Arm(s): CHL program | Intervention Type: OTHER; Name: Delayed Optimized CHL program; Assigned to Arm(s): Delayed Optimized CHL program
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: 6 months of healthy physical activity | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: 6 months of healthy physical activity; Assigned to Arm(s): 1

Answer: C